C4 Therapeutics

C4 Therapeutics (C4T) is a biopharmaceutical company focused on harnessing the body’s natural regulation of protein levels to develop novel therapeutic candidates to target and destroy disease-causing proteins for the treatment of cancer, neurodegenerative conditions and other diseases.

Industries

Headquarters

Cambridge, United States

Stage

Post IPO Equity

Employees

51-200

Links

Org chart

President & CEO

Collapse

Chief Scientific Officer

CFO

Chief Business Officer

Chief Legal Officer

Chief People Officer

SVP, Communications & IR

SVP, Strategic Alliances & Program Management

Mayra Reyes-Armour

VP, Technical Operations

Teams

View all

Board of Directors

13 members

Leadership Team

10 members

CEO and Executive Team

8 members

Founding Team

1 members

Discover similar companies

Corvus Pharmaceuticals

Burlingame, United States · Post IPO Equity

Magenta Therapeutics

Cambridge, United States · Post IPO Equity

Nabriva Therapeutics

King of Prussia, United States · Post IPO Equity

Stemline Therapeutics

New York, United States · Post IPO Equity

Krystal Biotech

Pittsburgh, United States · Post IPO Equity

Axsome Therapeutics

New York, United States · Post IPO Equity

Ovid Therapeutics

New York, United States · Post IPO Equity

Jounce Therapeutics

Cambridge, United States · Post IPO Equity

Translate Bio

Lexington, United States · Post IPO Equity

Arbutus Biopharma

Warminster, United States · Post IPO Equity

Quince Therapeutics

South San Francisco, United States · Post IPO Equity

Sigilon Therapeutics

Cambridge, United States · Post IPO Equity

Two candidates

The Org
helps you hire
great candidates

It takes less than ten minutes to set up your company page.
It’s free to use - try it out today.